SEATTLE and ATLANTA, Sept. 23 /PRNewswire/ -- Elekta’s leading-edge radiation oncology and neurosurgical products have been selected by Providence Health System, which operates 18 acute care facilities in four states. The health system has signed an exclusive, five-year provider contract with Elekta.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )
“Providence used several selection criteria in choosing the Elekta products,” said David Hunter, System Director of Supply Chain Management. “Among those were reliability, scope of products, service and reputation, value-added enhancements, and price. Elekta listened to our needs and demonstrated a commitment to helping us provide the highest level of patient care. We are pleased to offer our patients the benefit of these technologically-advanced tools.”
Elekta’s unique experience in image guidance and stereotactic applications in radiation treatment reaches back more than 30 years. On the basis of this experience and recent innovation, Elekta leads the development of new, advanced methods for ultra-precise radiation treatments.
“We are thrilled that a health system of Providence’s standing has awarded Elekta an exclusive contract for these vital systems,” said Anthony De Carolis, CEO of Elekta, Inc. and head of Elekta operations in North America. “After their experience with other manufacturers, Providence has decided Elekta can meet both the clinical and business requirements of their quality- focused health delivery facilities.”
Elekta’s radiation oncology and stereotactic radiosurgery solutions are readily available to 80 percent of acute care hospitals that report providing radiation therapy, thanks to contracts with several of the nation’s largest healthcare group purchasing organizations (GPOs).
About Providence Health System
Providence Health System extends its mission of caring and commitment across a four-state area -- Alaska, Washington, Oregon, and California. A comprehensive array of services is available to meet the varied needs of communities. These include acute and primary care, outpatient services, transitional care, home and hospice care, substance abuse programs, mental health treatment, comprehensive outreach programs including prevention and wellness, long term care, assisted living, and housing.
Providence Health System operates 18 acute care hospitals, 12 freestanding long term care facilities, and 20 low income and assisted living facilities. The system also works closely with its network of physician organizations and sponsors health plans covering more than 853,000 members and other eligible lives in Oregon and southwest Washington.
The health system’s four statewide regions are further divided into service areas, with nearly 34,000 employees serving within their respective geographic locations. The system office is located in Seattle, Washington.
About Elekta
Elekta is an international medical-technology group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include Leksell Gamma Knife(R) for non-invasive radiosurgery in the brain and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group became the world’s largest supplier of oncology software.
Elekta’s systems and solutions are used in over 3,000 hospitals around the world to treat cancer and to manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approximately 1,700 employees, Elekta’s corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGOPRN Photo Desk, photodesk@prnewswire.comElekta, Inc.
CONTACT: Michelle Lee, PR and Advertising Manager, +1-770-670-2447, ormichelle.lee@elekta.com; Investor inquiries, United States, Lars Jonsteg,VP Investor Relations North America, +46 708 78 37 35, orlars.jonsteg@elekta.com; International, Peter Ejemyr, Group VP CorporateCommunications, +46 733 611 000, or peter.ejemyr@elekta.com, all of Elekta,Inc.
Web site: http://www.elekta.com//
